|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Tamilvanan ShunmugaperumalPublisher: John Wiley & Sons Inc Imprint: John Wiley & Sons Inc Dimensions: Width: 1.00cm , Height: 1.00cm , Length: 1.00cm Weight: 0.482kg ISBN: 9781119585220ISBN 10: 1119585228 Pages: 464 Publication Date: 09 March 2021 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsList of Contributors ix Foreword xi Preface xiii 1. Introduction: An Overview of Nanosized Emulsions 1 2. Formulation Development of Oil-In-Water Nanosized Emulsions 19 3. Characterization and Safety Assessment F Oil-In-Water Nanosized Emulsions 69 4. Manufacturing and Positioning (Generations) of Oil-In-Water Nanosized Emulsions 169 5. Biofate of Nanosized Emulsions 225 6. Medical or Therapeutical Applications of Oil-In-Water Nanosized Emulsions 259 Part I: Overview of Tocol-Based Emulsions, Oxygen-Carrying Emulsions, Emulsions With Double or Triple Cargos and Emulsion-Like Dispersions 287 7. Overview of Tocol‐Based Emulsions, Oxygen‐Carrying Emulsions, Emulsions With Double or Triple Cargos and Emulsion‐Like Dispersions 289 7.1. Tocol-Based Nanosized Emulsions 291 7.2. Oxygen-Carrying Emulsions 301 7.3. Nanosized Emulsions For Multiple Medicament Loadings, Imaging, and Theranostic Purposes 321 7.4. Emulsion-Like Dispersions 347 Part II: Selected Case Studies 369 8. Selected Case Studies 371 8.1. Case Study 1 - Cationic Nanosized Emulsions: Narration of Commercial Success 373 8.2. Case Study 2 - Fish Oil-Based Nanosized Emulsions 389 Index 423ReviewsAuthor InformationTamilvanan Shunmugaperumal, PhD, works at the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India. His current research focuses on systematic optimization of formula to prepare various pharmaceutical dosage forms such as solid lipid microparticles, nanosized emulsions, and microspheres, where he seeks to exploit the potential of lipid- and polymer-based drug delivery carriers to eradicate infectious biofilm formation associated with both medical devices and human organs. Tab Content 6Author Website:Countries AvailableAll regions |